Abstract:
A device and process for reinforcing underwater structures of branched joints having a main element (1) and at least one secondary element (2), one end to which is integral with the surface of element (1). The device incorporates a flange (3, 3'), a first portion (3') of which is initially fixed to the secondary element (2), and a second portion (3') of which is thereafter fixed to the first portion. The flange portions define an annular space between the flange and the elements. A liquid composition which generates an elastic polymerized material (4) is introduced into an enclosure to fill the annular space and encapsulate the flange, which enclosure defines the outer boundary of the polymerized material (4).
Abstract:
Purified enzymatic preparation derived from Chromobacterium violaceum, having a dehydrogenase activity, method for preparing it and its use in the production of .alpha.,.beta.-dehydrotryptophanyl-peptides.The said method for preparing .alpha.,.beta.-dehydrotryptophanyl-peptides and .alpha.,.beta.-dehydrotryptophanyl-proteins is characterised in that one brings into contact:a peptide or a protein to be converted, anda purified enzymatic preparation having an L-tryptophan dehydrogenase activity and having a specific activity of between 35 and 45 units.seconds.sup.-1 per mole of heme for N-acetyl-L-tryptophanamide (NATA), an apparent molecular weight of the order of 680 kDa, an isoelectric point of the order of 4, a temperature optimum for activity greater than 80.degree. C. and a temperature stability, at a pH of between 3 and 8 and at a temperature of between 20.degree. and 60.degree. C.Use of the dehydropeptides and dehydroproteins obtained as probes, reagents, drugs or cosmetic products.
Abstract:
Use of CDSs in the synthesis of linear dipeptides, and applications thereof for the in vivo and in vitro synthesis of linear dipeptides, in particular Phe-Leu, Leu-Phe, Phe-Phe, Phe-Tyr, Tyr-Phe, Leu-Leu, Leu-Tyr, Tyr-Leu, Phe-Met, Met-Phe, Leu-Met, Met-Leu, Tyr-Met, Met-Tyr, Met-Met, Tyr-Tyr, Ile-Met, Met-Ile, Leu-Ile, Ile-Leu using the corresponding polynucleotides.
Abstract:
The invention concerns novel isolated natural or synthetic polynucleotides and polypeptides coded by said polynucleotides, involved in the synthesis of diketopiperazine derivatives, vectors comprising said polynucleotides, micro-organisms transformed with said polynucleotides, uses of said polynucleotides and said polypeptides, as well as methods for the synthesis of diketopiperazine derivatives, including cyclodipeptides and diketopiperazine derivatives 3- and 6- substituted by α,β-unsaturated amino acid side chains.
Abstract:
Isolated, natural or synthetic polynucleotides and the polypeptides encoded by said polynucleotides, that are involved in the synthesis of cyclodipeptides, the recombinant vectors comprising said polynucleotides or any substantially homologous polynucleotides, the host cell modified with said polynucleotides or said recombinant vectors and also methods for in vitro and in vivo synthesizing cyclo(Leu-Leu) cyclodipeptide and its derivatives and applications thereof.
Abstract:
The invention concerns novel isolated natural or synthetic polynucleotides and polypeptides coded by said polynucleotides, involved in the synthesis of diketopiperazine derivatives, vectors comprising said polynucleotides, micro-organisms transformed with said polynucleotides, uses of said polynucleotides and said polypeptides, as well as methods for the synthesis of diketopiperazine derivatives, including cyclodipeptides and diketopiperazine derivatives 3- and 6-substituted by α,β-unsaturated amino acid side chains.
Abstract:
The invention concerns novel isolated natural or synthetic polynucleotides and polypeptides coded by said polynucleotides, involved in the synthesis of diketopiperazine derivatives, vectors comprising said polynucleotides, micro-organisms transformed with said polynucleotides, uses of said polynucleotides and said polypeptides, as well as methods for the synthesis of diketopiperazine derivatives, including cyclodipeptides and diketopiperazine derivatives 3- and 6-substituted by α,β-unsaturated amino acid side chains.
Abstract:
Isolated, natural or synthetic polynucleotide and polypeptide encoded by said polynucleotide, that is involved in the synthesis of cyclodipeptides, recombinant vector comprising said polynucleotide or any substantially homologous polynucleotide, host cell modified with said polynucleotide or said recombinant vector and also methods for in vitro and in vivo synthesizing cyclodipeptides, in particular cyclo(Tyr-Xaa) cyclodipeptides, wherein Xaa is any amino acid and their derivatives and applications thereof.
Abstract:
The invention concerns novel isolated natural or synthetic polynucleotides and polypeptides coded by said polynucleotides, involved in the synthesis of diketopiperazine derivatives, vectors comprising said polynucleotides, micro-organisms transformed with said polynucleotides, uses of said polynucleotides and said polypeptides, as well as methods for the synthesis of diketopiperazine derivatives, including cyclodipeptides and diketopiperazine derivatives 3- and 6- substituted by α,β-unsaturated amino acid side chains.